Optellum, AI Lung Cancer Diagnosis Innovator,
Secures $14M Series A Funding to Accelerate Expansion

Lead investor Mercia, alongside Intuitive Ventures and Black Opal, invests inOptellum’s pioneering AI-powered lung-health technology Oxford, 27 September 2022, 8am: Optellum, an Oxford-based medtech company that provides a breakthrough AI…

Continue ReadingOptellum, AI Lung Cancer Diagnosis Innovator,
Secures $14M Series A Funding to Accelerate Expansion

PRESS RELEASE: CMS assigns new technology payment classification for Optellum’s Lung Cancer Prediction score

This payment assignment to a newly available Healthcare Common Procedure Coding System (HCPCS) code constitutes an important step towards reimbursing providers for the use of Optellum’s transformative technology with Medicare…

Continue ReadingPRESS RELEASE: CMS assigns new technology payment classification for Optellum’s Lung Cancer Prediction score

PRESS RELEASE: Optellum attains CE marking for its early lung cancer diagnosis AI technology

Optellum Virtual Nodule Clinic, including its proprietary artificial intelligence lung cancer prediction solution, has achieved CE certification under the European Union’s Medical Device Regulation. Oxford, UK – 30 March 2022:…

Continue ReadingPRESS RELEASE: Optellum attains CE marking for its early lung cancer diagnosis AI technology